Clinical Trial Update: Evaluation of VGX-3100 and Electroporation Alone or in Combination With Imiquimod for the Treatment of HPV-16 and/or HPV-18 Related Vulvar HSIL (Also Referred as: VIN 2 or VIN 3) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating VGX-3100 with electroporation, alone or with imiquimod, for HPV-16/18 related vulvar HSIL (VIN 2/3); study completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvar Dysplasia
• Vulvar High-grade Squamous Intraepithelial Lesion
• Vulvar Intraepithelial Neoplasia

Drugs mentioned

• Imiquimod (imiquimod)
• VGX-3100

Snippet

Sponsor: Inovio Pharmaceuticals | Conditions: Vulvar High Grade Squamous Intraepithelial Lesion (HSIL), Vulvar Dysplasia | Phase 2 | Status: COMPLETED | Results posted: 2023-08-25